Eli Lilly led a Stocktwits poll, with 32% support, ahead of Novo Nordisk, Hims & Hers Health and Viking Therapeutics at 16%. ...

PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Investing in pharmaceutical companies with robust product pipelines and diversified revenue streams is often considered a ...

DelveInsight's Rheumatoid Arthritis Market Insights report includes a comprehensive understanding of current treatment practices, rheumatoid arthritis emerging drugs, market share of individual ...

A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic ...

Michigan Attorney General Dana Nessel's office is asking the court to overturn two previous rulings and allow an investigation into Eli Lilly and Co.

The office of Michigan’s attorney general on Wednesday again urged the state Supreme Court to overturn two prior rulings that it says hamstring its desire to investigate Eli Lilly & Co.’s insulin ...

Pfizer and Novo Nordisk seem to want Metsera bad. Analysts are wondering, though: is the obesity biotech really worth this much effort?

The Michigan Supreme Court will decide whether to overturn past precedent to clear the way for an attorney general probe into ...

Last year, China-based Jiangsu Hengrui Pharmaceuticals overtook the U.K.’s AstraZeneca as the top clinical trial sponsor in ...

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...